Amedeo Smart

Free Medical Literature Service



Breast Cancer

  Free Subscription

Articles published in
    June 2018
  1. BAE SY, Jung SP, Jung ES, Park SM, et al
    Clinical Characteristics and Prognosis of Pregnancy-Associated Breast Cancer: Poor Survival of Luminal B Subtype.
    Oncology. 2018 Jun 18:1-7. doi: 10.1159/000488944.
    >> Share

    May 2018
  2. CORSO G, Maisonneuve P, Santomauro GI, De Scalzi AM, et al
    Ipsilateral Breast Tumor Reappearance and Contralateral Breast Cancer after Primary Breast Cancer Treatment: A Comprehensive Retrospective Study of 15,168 Patients.
    Oncology. 2018 May 30:1-9. doi: 10.1159/000488764.
    >> Share

  3. LANDRY S, Chasles G, Pointreau Y, Bourgeois H, et al
    Influence of an Adapted Physical Activity Program on Self-Esteem and Quality of Life of Breast Cancer Patients after Mastectomy.
    Oncology. 2018 May 30:1-4. doi: 10.1159/000489265.
    >> Share

    January 2018
  4. LEE SJ, Lee J, Kim WW, Jung JH, et al
    Del-1 Expression as a Potential Biomarker in Triple-Negative Early Breast Cancer.
    Oncology. 2018 Jan 31. pii: 000485658. doi: 10.1159/000485658.
    >> Share

  5. JIA S, Miedel MT, Ngo M, Hessenius R, et al
    Clinically Observed Estrogen Receptor Alpha Mutations within the Ligand-Binding Domain Confer Distinguishable Phenotypes.
    Oncology. 2018;94:176-189.
    >> Share

  6. ISHITOBI M, Fukui R, Hashimoto Y, Kittaka N, et al
    pTis and pT1a Ipsilateral Breast Tumor Recurrence Is Associated with Good Prognosis after Salvage Surgery.
    Oncology. 2018;94:12-18.
    >> Share

    November 2017
  7. KAWAHARA T, Shimozuma K, Shiroiwa T, Hagiwara Y, et al
    Patient-Reported Outcome Results from the Open-Label Randomized Phase III SELECT BC Trial Evaluating First-Line S-1 Therapy for Metastatic Breast Cancer.
    Oncology. 2017 Nov 17. doi: 10.1159/000484142.
    >> Share

  8. HOKIMOTO N, Sugimoto T, Namikawa T, Funakoshi T, et al
    A Novel Color Fluorescence Navigation System for Intraoperative Transcutaneous Lymphatic Mapping and Resection of Sentinel Lymph Nodes in Breast Cancer: Comparison with the Combination of Gamma Probe Scanning and Visible Dye Methods.
    Oncology. 2017 Nov 10. doi: 10.1159/000484050.
    >> Share

    September 2017
  9. GAL O, Ishai Y, Sulkes A, Shochat T, et al
    Early Breast Cancer in the Elderly: Characteristics, Therapy, and Long-Term Outcome.
    Oncology. 2017 Sep 27. doi: 10.1159/000480087.
    >> Share

    August 2017
  10. MUKAI H, Hagiwara Y, Imi K, Isaka H, et al
    The Impact of Treatment Preferences in Second-Line Chemotherapy on the Prognosis of HER2-Negative Metastatic Breast Cancer.
    Oncology. 2017 Aug 24. doi: 10.1159/000479033.
    >> Share

  11. AARTS MJ, Vriens BE, de Boer M, Peters FP, et al
    Neutrophil Recovery in Breast Cancer Patients Receiving Docetaxel-Containing Chemotherapy with and without Granulocyte Colony-Stimulating Factor Prophylaxis.
    Oncology. 2017 Aug 22. doi: 10.1159/000479067.
    >> Share

    June 2017
    Optimizing Quality of Life in Patients with Hormone Receptor-Positive Metastatic Breast Cancer: Treatment Options and Considerations.
    Oncology. 2017 Jun 15. doi: 10.1159/000477404.
    >> Share

    May 2017
  13. NISHIMURA R, Toh U, Tanaka M, Saimura M, et al
    Role of HER2-Related Biomarkers (HER2, p95HER2, HER3, PTEN, and PIK3CA) in the Efficacy of Lapatinib plus Capecitabine in HER2-Positive Advanced Breast Cancer Refractory to Trastuzumab.
    Oncology. 2017;93.
    >> Share

    March 2017
  14. STUBER T, Novopashenny I, Diessner J, Bartmann C, et al
    Are There Breast Cancer Patients with Node-Negative Small Tumours, Who Do Not Benefit from Adjuvant Systemic Therapy?
    Oncology. 2017 Mar 24. doi: 10.1159/000455050.
    >> Share

    February 2017
  15. DOHOU J, Mouret-Reynier MA, Kwiatkowski F, Arbre M, et al
    A Retrospective Study on the Onset of Menopause after Chemotherapy: Analysis of Data Extracted from the Jean Perrin Comprehensive Cancer Center Database Concerning 345 Young Breast Cancer Patients Diagnosed between 1994 and 2012.
    Oncology. 2017 Feb 8. doi: 10.1159/000455049.
    >> Share

    January 2017
  16. KIM HY, Jung YJ, Lee SH, Jung HJ, et al
    Is Beta-Blocker Use Beneficial in Breast Cancer? A Meta-Analysis.
    Oncology. 2017 Jan 28. doi: 10.1159/000455143.
    >> Share

  17. SNIDER 3RD JW, Mutaf Y, Nichols E, Hall A, et al
    Dosimetric Improvements with a Novel Breast Stereotactic Radiotherapy Device for Delivery of Preoperative Partial-Breast Irradiation.
    Oncology. 2017;92:21-30.
    >> Share

    December 2016
  18. LEE SJ, Kang BW, Kim JG, Jung JH, et al
    AQP5 Variants Affect Tumoral Expression of AQP5 and Survival in Patients with Early Breast Cancer.
    Oncology. 2016.
    >> Share

    September 2016
  19. KIM HS, Lee SY, Kim JW, Choi YJ, et al
    Incidence and Predictors of Febrile Neutropenia among Early-Stage Breast Cancer Patients Receiving Anthracycline-Based Chemotherapy in Korea.
    Oncology. 2016.
    >> Share

    August 2016
  20. KIESEWETTER B, Lukas J, Dolak W, Simonitsch-Klupp I, et al
    Gender Aspects in Extranodal Marginal Zone B-Cell Lymphoma of the Mucosa-Associated Lymphoid Tissue: Does Sex Matter?
    Oncology. 2016.
    >> Share

  21. GOLDVASER H, Rizel S, Hendler D, Neiman V, et al
    The Association between Angiotensin Receptor Blocker Usage and Breast Cancer Characteristics.
    Oncology. 2016;91.
    >> Share

    June 2016
  22. WINN JS, Baker MG, Fanous IS, Slack-Davis JK, et al
    Lobular Breast Cancer and Abdominal Metastases: A Retrospective Review and Impact on Survival.
    Oncology. 2016.
    >> Share

Free Medical Abstracts
Privacy Policy

© Amedeo 1997-2016